Mach7 Technologies, 3D Medical Limited sign agreement to merge, go public on Australian stock market

Mach7 Technologies, an enterprise image management company based out of Burlington, Vt., and 3D Medical Limited, a medical-specific Australian 3D printing business, have signed a definitive agreement to merge.

The merger, once finalized, will produce a merged company that will be publicly listed on the Australian stock market and traded as “Mach 7 Technologies Ltd.”

The two companies already have a history of working together. 3D Medical Limited is the exclusive reseller of Mach7 image management products for hospitals and radiology clinics throughout Australia and New Zealand.

"We are delighted to have secured an agreement to bring our companies together," Nigel Finch, 3D Medical Limited chairman, said in a statement. "We have enjoyed a close working relationship with Mach7 and admire their outstanding success in the USA and Asia. This transaction delivers a material revenue boost to 3DM and importantly allows 3DM shareholders to benefit from the ownership of best-in-breed healthcare imaging intellectual property. The transaction will drive earnings and transform the combined entity into a global operation, allowing significant opportunities to scale 3DM’s value-adding data activities to leading healthcare institutions globally."

"Access to new capital will enable us to surpass business and product roadmap goals in a shorter time frame and to better serve our customers," Albert Liong, Mach7 CEO, said in the same statement. "Mach7 has enjoyed substantial growth in recent years, and we feel this will be enhanced with access to the public capital market.”